Table 2 Lipid profile and eGFR among study population
Mean blood pressure | ||
|---|---|---|
Systolic | 138 mmHg | (18.3) |
Diastolic | 76 mmHg | (10.5) |
Mean lipid profile | ||
TC | 5.0 mmol/L | (0.9) |
LDL | 3.1 mmol/L | (0.8) |
HDL | 1.2 mmol/L | (0.3) |
TG | 1.6 mmol/L | (1.1) |
Total cholesterol* | ||
<5.2 | 60.9% | |
5.2-6.2 | 28.8% | |
>6.2 | 9.9% | |
LDL* | ||
<2.6 | 30.4% | |
2.6-3.3 | 35.9% | |
3.4-4.1 | 23.2% | |
4.1-4.9 | 7.4% | |
>4.9 | 2.1% | |
HDL* | ||
<1.0 | 16.5% | |
1.0-1.5 | 53.6% | |
>1.5 | 29.5% | |
TG* | ||
<1.7 | 68.1% | |
1.7-2.2 | 16.4% | |
2.3-5.6 | 14.1% | |
>5.6 | 1.0% | |
Mean eGFR (ml/min/1.73 m2) | 84.8 | (23.2) |
Chronic kidney disease* | ||
Stage 1 | 38.5% | |
Stage 2 | 48.8% | |
Stage 3 | 11.7% | |
Stage 4 | 0.3% | |
Stage 5 | 0.1% | |
Mean urine ACR | 10.2 mg/mmol | (42.7) |
Proportion normal | 67.9% | |